Opexa Therapeutics to Present at BMO Capital Markets Focus on ...
PharmaLive.com (press release) - Newtown,PA,USA
... cell therapies. The Company's lead product, Tovaxin(TM),
a T-cell therapy for multiple sclerosis is in Phase IIb trials.
The Company ...